Clinical Trial Update: Eosinophil-driven Corticotherapy for Patients Hospitalized for COPD Exacerbation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update investigating eosinophil-driven corticotherapy for patients hospitalized with COPD exacerbation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COPD Exacerbation
• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: University Hospital, Montpellier | Conditions: COPD Exacerbation | Phase 3 | Status: UNKNOWN